Pramipexole Dihydrochloride Tablet, Extended Release
Product Images NDC 71034-003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pramipexole Dihydrochloride (NDC 71034-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiamen Lp Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Pramipexole 01)

FDA Label Image

Tablet-pictures (Pramipexole 02)

FDA Label Image

Bottle-label-0.375mg (Pramipexole 03)

Bottle-label-0.375mg (Pramipexole 03)
This is a medication description for Pramipexole Dihydrochloride. The product has a Global Trade Item Number (GTIN) of XHXOXXXXXXXXXXXXX, and Serial Number (SN) of XXXXXXXX. The medication comes in tablets that must be swallowed whole and not chewed, crushed, or divided. The dosage instructions should be accessed via the prescribing information. The Lot Number for this product is XXXXXXXXX, and it should be stored at 25°C (77°F) with excursions permitted to 15°to 30°C (59° to 86°F), protected from high humidity. The medication has a strength expressed as Pramipexole Dihydrochloride Monohydrate equivalent to 0.352 mg Pramipexole Dihydrochloride. This medication should be kept out of reach of children, and dispensed in the original unit of use container. The manufacturer is Xiamen LP Pharmaceutical Co., located in Xiamen, Fujian, China.*
FDA Label Image

Bottle-label-0.75mg (Pramipexole 04)

Bottle-label-0.75mg (Pramipexole 04)
NDC 71034-003-30 30 Tablets of Pramipexole Dihydrochloride Extended-Release. This medication is indicated for the treatment of Parkinson's disease and restless legs syndrome. Tablet strength is 0.75mg expressed as pramipexole dihydrochloride monohydrate equivalent to 0.705mg of pramipexole dihydrochloride. Dosage information and prescribing information should be read carefully. The tablets should not be chewed, crushed, or divided but swallowed whole. Keep out of children's reach, protect against high humidity and store at 25°C (77°F) with excursions permitted to 15° to 30°C (59° to 86°F). This medication is manufactured by Xiamen LP Pharmaceutical Co., Ltd. in Xiamen, Fujian, China. The revision is from August 2020. GTIN, SN, EXP, LOT info not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.